SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Phaarmasia - Quaterly Results

07 Feb 2026 Evaluate
The total revenue hovered 239.92% to Rs. 160.51 millions for the December 2025 quarter as against Rs. 47.22 millions during the corresponding quarter last year.The Total Profit for the quarter ended December 2025 of Rs. 162.74 millions grew from Rs.-7.00 millions Operating profit Margin for the quarter ended December 2025 improved to 10.00% as compared to -6.04% of corresponding quarter ended December 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 160.51 47.22 239.92 394.76 189.39 108.44 243.69 305.93 -20.34
Other Income 1.62 1.90 -14.74 6.17 5.63 9.59 7.46 6.62 12.69
PBIDT 10.00 -6.04 -265.56 31.58 -8.36 -477.75 -12.67 -1.58 701.90
Interest 0.18 0.08 125.00 0.46 0.14 228.57 0.16 0.44 -63.64
PBDT 199.77 -6.12 -3364.22 221.07 -8.50 -2700.82 -12.83 -2.02 535.15
Depreciation 0.61 0.82 -25.61 1.80 2.41 -25.31 3.20 3.44 -6.98
PBT 199.16 -6.94 -2969.74 219.27 -10.91 -2109.81 -16.03 -5.46 193.59
TAX 36.42 0.06 60600.00 36.47 -0.26 -14126.92 -0.13 -0.28 -53.57
Deferred Tax -0.68 0.06 -1233.33 -0.63 -0.26 142.31 -0.13 -0.28 -53.57
PAT 162.74 -7.00 -2424.86 182.80 -10.65 -1816.43 -15.90 -5.18 206.95
Equity 68.27 68.27 0.00 68.27 68.27 0.00 68.27 68.27 0.00
PBIDTM(%) 6.23 -12.79 -148.71 8.00 -4.41 -281.23 -5.20 -0.52 906.62

Phaarmasia Share Price

102.14 4.31 (4.41%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×